ARTICLES BY VECTRON BIOSOLUTIONS

Tech Innovations

Towards A New Industry Standard For Bacterial Protein Production

Selective secretion by E. coli will bring a revolutionary improvement in ease and cost of recombinant protein production processes.

Business

The value of patent protection for bacterial production strains

Vectron’s unique strain development processes can enable patenting of the resulting production strain.

Business

Regulatory considerations when selecting a development partner

Ensuring regulatory success begins with a reliable expression system.

Business

How to bring clinically approved and commercially viable products to market quickly and efficiently

Trond Erik Vee Aune, Head of Vectron Bioslolutions, shares his experience and learnings from over a decade of working with drug-developing companies.

Tech Innovations

Vector Expression Technologies for Boosting Protein Production in E. coli

We recently had the pleasure to talk with David from Pharma Almanac, who wanted to know more about Vectron's microbial protein production technologies

Business

Carina Morocco from EBD Group interviews Trond Aune our CEO

A conversation about current trends in recombinant protein production and how we adapt our technology to face the new challenges in the industry.

Business

Vectron expands into the specialized enzyme market

The company's technologies can also be used to develop...

Tech Innovations

Soluble production of Proinsulin in the cytoplasm E. coli

Proinsulins are notoriously difficult proteins to produce...

Tech Innovations

N-terminal fusion partners for elevated titers

In Vectron we use two different types of 5' fusion...

Tech Innovations

Introducing VB Evolution

If every protein is unique, they require unique vectors...

Tech Innovations

Expression Bottlenecks Chapter 1: Suboptimal transcription

The design of vectors for industrial production...

Business

This is Vectron Biosolutions

Vectron Biosolutions was founded in 2008...